WallStreetZenWallStreetZen

NASDAQ: CMPX
Compass Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CMPX

Based on 2 analysts offering 12 month price targets for Compass Therapeutics Inc.
Min Forecast
$8.00+467.38%
Avg Forecast
$9.00+538.3%
Max Forecast
$10.00+609.22%

Should I buy or sell CMPX stock?

Based on 2 analysts offering ratings for Compass Therapeutics Inc.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CMPX stock forecasts and price targets.

CMPX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-16
lockedlocked$00.00+00.00%2024-03-22

1 of 1

Forecast return on equity

Is CMPX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
27.86%

Forecast return on assets

Is CMPX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CMPX revenue forecast

What is CMPX's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$18.7M
Avg 2 year Forecast
$70.5M
Avg 3 year Forecast
$178.0M

CMPX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CMPX$1.41$9.00+538.30%Buy
CGEN$2.17$4.00+84.33%Strong Buy
CLLS$2.71$6.00+121.40%Buy
ZVRA$4.65$15.00+222.58%Buy
OMER$3.36N/AN/A
View Top Biotech Stocks

Compass Therapeutics Stock Forecast FAQ

Is Compass Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: CMPX) stock is to Buy CMPX stock.

Out of 2 analysts, 0 (0%) are recommending CMPX as a Strong Buy, 2 (100%) are recommending CMPX as a Buy, 0 (0%) are recommending CMPX as a Hold, 0 (0%) are recommending CMPX as a Sell, and 0 (0%) are recommending CMPX as a Strong Sell.

If you're new to stock investing, here's how to buy Compass Therapeutics stock.

What is CMPX's revenue growth forecast for 2025-2027?

(NASDAQ: CMPX) Compass Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.39%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.64%.

Compass Therapeutics's revenue in 2024 is $0.On average, 2 Wall Street analysts forecast CMPX's revenue for 2025 to be $2,566,038,039, with the lowest CMPX revenue forecast at $1,692,346,803, and the highest CMPX revenue forecast at $3,439,729,275. On average, 6 Wall Street analysts forecast CMPX's revenue for 2026 to be $9,702,100,393, with the lowest CMPX revenue forecast at $1,795,538,682, and the highest CMPX revenue forecast at $20,594,622,294.

In 2027, CMPX is forecast to generate $24,494,174,578 in revenue, with the lowest revenue forecast at $11,739,108,070 and the highest revenue forecast at $51,040,629,231.

What is CMPX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CMPX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CMPX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CMPX price target, the average CMPX price target is $9.00, with the highest CMPX stock price forecast at $10.00 and the lowest CMPX stock price forecast at $8.00.

On average, Wall Street analysts predict that Compass Therapeutics's share price could reach $9.00 by May 16, 2025. The average Compass Therapeutics stock price prediction forecasts a potential upside of 538.3% from the current CMPX share price of $1.41.

What is CMPX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CMPX) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.